Delivery Order SPE2DB20D1100-SPE2DB25FE5U4
- Not listed
- This federal contract award is a delivery order for Atorvastatin 20 mg tablets in quantities of 1,000 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,522.07 firm fixed-price contract has a completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,150.18 firm fixed-price delivery order contract is to provide AMLODIPINE-ATORVAST 10-20 MG 30S, a cardiovascular medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency Troop Support Medical awarded a $14,240 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for atorvastatin calcium. As the prime contractor, Amerisourcebergen Drug Corp will deliver the generic cholesterol-lowering drug from its facility in Conshohocken, Pennsylvania to fulfill DLA Troop Support Medical's requirements. The single day contract period of June 28 through 29, 2023 indicates this was likely an urgent order to replenish stock of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $49,760 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 90 tablets of 80mg atorvastatin. The delivery order was issued against an existing DLA medical supply vehicle and requires Amerisourcebergen to deliver the generic cholesterol medication to a facility in Conshohocken, Pennsylvania by September 18, 2023. No set aside provisions or...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $51,480 to Amerisourcebergen Drug Corporation. The order is for 4562004354 units of atorvastatin 10mg tablets to be delivered by August 31, 2023 from the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract as the prime contractor. The Defense Logistics Agency routinely issues delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the generic cholesterol-lowering medication from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by September 12, 2023 under the terms of the order. Amerisourcebergen Corporation is the parent company of Amerisourcebergen...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at seventy-four thousand six hundred and sixty-four dollars to Amerisourcebergen Drug Corporation for the supply of ninety boxes containing eighty milligram tablets of atorvastatin. Amerisourcebergen Drug Corporation will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania by June 29, 2023 in support of the Defense Logistics Agency's medical supply requirements. As the...
- On July 28, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,078.79 to AmerisourceBergen Drug Corp for the supply of Telmisartan-Amlodipine 80-5 mg tablets (30-count). This firm fixed-price delivery order is non-competitive and carries an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5U4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Amlodipine-Atorvastatin 10-20 mg in 30-count packages. This firm fixed-price delivery order, valued at $3,920.43, is a non-set-aside competitive award supporting federal medical procurement needs. The contract represents performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support global military healthcare programs. The company's portfolio of federal contract awards demonstrates proven capability to meet federal procurement requirements through open competition, with delivery orders typically structured as firm fixed-price arrangements ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/10/25 |